341 related articles for article (PubMed ID: 15339979)
1. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton.
Rico-Bautista E; Negrín-Martínez C; Novoa-Mogollón J; Fernández-Perez L; Flores-Morales A
Exp Cell Res; 2004 Mar; 294(1):269-80. PubMed ID: 14980520
[TBL] [Abstract][Full Text] [Related]
3. Cardiac resistance to growth hormone in uremia.
Zheng Z; Sun DF; Tummala P; Rabkin R
Kidney Int; 2005 Mar; 67(3):858-66. PubMed ID: 15698425
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
5. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
7. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance.
Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D
J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818
[TBL] [Abstract][Full Text] [Related]
8. Prolactin and growth hormone signaling.
Chilton BS; Hewetson A
Curr Top Dev Biol; 2005; 68():1-23. PubMed ID: 16124994
[TBL] [Abstract][Full Text] [Related]
9. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.
Schaefer F; Chen Y; Tsao T; Nouri P; Rabkin R
J Clin Invest; 2001 Aug; 108(3):467-75. PubMed ID: 11489940
[TBL] [Abstract][Full Text] [Related]
10. Regulation of signal transducer and activator of transcription (STAT) 5b activation by the temporal pattern of growth hormone stimulation.
Gebert CA; Park SH; Waxman DJ
Mol Endocrinol; 1997 Apr; 11(4):400-14. PubMed ID: 9092792
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.
Rabkin R; Sun DF; Chen Y; Tan J; Schaefer F
Pediatr Nephrol; 2005 Mar; 20(3):313-8. PubMed ID: 15692835
[TBL] [Abstract][Full Text] [Related]
12. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
13. Impairment of liver GH receptor signaling by fasting.
Beauloye V; Willems B; de Coninck V; Frank SJ; Edery M; Thissen JP
Endocrinology; 2002 Mar; 143(3):792-800. PubMed ID: 11861499
[TBL] [Abstract][Full Text] [Related]
14. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.
Freeth JS; Silva CM; Whatmore AJ; Clayton PE
Endocrinology; 1998 Jan; 139(1):20-8. PubMed ID: 9421393
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin attenuates growth hormone-induced hepatic insulin-like growth factor I expression by inhibiting JAK2/STAT5 signal transduction and STAT5b DNA binding.
Chen Y; Sun D; Krishnamurthy VM; Rabkin R
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1856-62. PubMed ID: 17327369
[TBL] [Abstract][Full Text] [Related]
16. Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis.
Held MA; Cosme-Blanco W; Difedele LM; Bonkowski EL; Menon RK; Denson LA
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G986-93. PubMed ID: 15604202
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E600-7. PubMed ID: 15899943
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo.
Mao Y; Ling PR; Fitzgibbons TP; McCowen KC; Frick GP; Bistrian BR; Smith RJ
Endocrinology; 1999 Dec; 140(12):5505-15. PubMed ID: 10579313
[TBL] [Abstract][Full Text] [Related]
19. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
